Evidence map›Paper›PMID 35858541›Full record

ArticleCell reports2022

Direct type I interferon signaling in hepatocytes controls malaria.

Camila Marques-da-Silva, Kristen Peissig, Michael P Walker, Justine Shiau, Carson Bowers, Dennis E Kyle, Rahul Vijay, Scott E Lindner, Samarchith P Kurup

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Flp/Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  7. Review
  8. Article
  9. Article
  10. Human transcriptional signature of protection afterHuman vaccines & immunotherapeutics · 2023
    Article
  11. AIM2 sensors mediate immunity toProceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  12. Cryopreservation ofPathogens (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Camila Marques-da-SilvaDepartment of Cellular Biology, University of Georgia, Athens, GA, USA; Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, GA, USA.
Kristen PeissigDepartment of Cellular Biology, University of Georgia, Athens, GA, USA; Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, GA, USA.
Michael P WalkerDepartment of Biochemistry and Molecular Biology, The Huck Center for Malaria Research, Pennsylvania State University, University Park, PA, USA.
Justine ShiauCenter for Tropical and Emerging Global Diseases, University of Georgia, Athens, GA, USA; Department of Infectious Diseases, University of Georgia, Athens, GA, USA.
Carson BowersCenter for Tropical and Emerging Global Diseases, University of Georgia, Athens, GA, USA.
Dennis E KyleDepartment of Cellular Biology, University of Georgia, Athens, GA, USA; Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, GA, USA; Department of Infectious Diseases, University of Georgia, Athens, GA, USA.
Rahul VijayCenter for Cancer Cell Biology, Immunology and Infection, Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA.
Scott E LindnerDepartment of Biochemistry and Molecular Biology, The Huck Center for Malaria Research, Pennsylvania State University, University Park, PA, USA.
Samarchith P KurupDepartment of Cellular Biology, University of Georgia, Athens, GA, USA; Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, GA, USA. Electronic address: samar@uga.edu.
University of Georgia · USPennsylvania State University · USRosalind Franklin University of Medicine and Science · US

Funding

Training in Tropical and Emerging Global Diseases - SupplementT32AI060546 · NIAID · UNIVERSITY OF GEORGIA (UGA) · PI Silvia N Moreno, Vasant Muralidharan · 2004 to 2026
$5.1M
Type-I Interferons drive cell-autonomous immunity to malariaR01AI168307 · NIAID · UNIVERSITY OF GEORGIA · PI KURUP, SAM · 2022 to 2025
$1.9M
Combining Liver Stage Culture System with Backcross Genetics to Discover Antimalarial Drug Resistance LociR21AI144591 · NIAID · UNIVERSITY OF GEORGIA · PI KYLE, DENNIS E · 2019 to 2020
$415k
Ribozyme Guided CRISPRi in Human- and Rodent-Infectious Plasmodium speciesR21AI130692 · NIAID · PENNSYLVANIA STATE UNIVERSITY, THE · PI LINDNER, SCOTT E · 2017 to 2018
$411k
NIAID NIH HHS R01 AI168307NIAID NIH HHS R21 AI130692NIAID NIH HHS R21 AI144591NIAID NIH HHS T32 AI060546
6 · The paper itself

Abstract

Malaria is a devastating disease impacting over half of the world's population. Plasmodium parasites that cause malaria undergo obligatory development and replication in hepatocytes before infecting red blood cells and initiating clinical disease. While type I interferons (IFNs) are known to facilitate innate immune control to Plasmodium in the liver, how they do so has remained unresolved, precluding the manipulation of such responses to combat malaria. Utilizing transcriptomics, infection studies, and a transgenic Plasmodium strain that exports and traffics Cre recombinase, we show that direct type I IFN signaling in Plasmodium-infected hepatocytes is necessary to control malaria. We also show that the majority of infected hepatocytes naturally eliminate Plasmodium infection, revealing the potential existence of anti-malarial cell-autonomous immune responses in such hepatocytes. These discoveries challenge the existing paradigms in Plasmodium immunobiology and are expected to inspire anti-malarial drugs and vaccine strategies.

Indexed as

AntimalarialsInterferon Type IMalariaPlasmodiumAnimalsHepatocytesHumansImmunity, InnateLiverSporozoitesAntimalarialsInterferon Type Icell-intrinsic immunityCP: ImmunologyCP: MicrobiologyCreCRISPR-Cas9hepatocytesliverliver-stagemalariaPlasmodiumsporozoitestype I interferons

Identifiers

PMID35858541
PMCPMC9422951
OpenAlexW4286250329

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.